BioCentury
ARTICLE | Financial News

Brandon Capital closes A$200M life science fund

April 21, 2015 1:38 AM UTC

Brandon Capital raised A$200 million ($156.3 million) for its Medical Research Commercialisation Fund (MRCF3), which the firm said is Australia's largest life science venture fund to date. Existing investors AustralianSuper and Statewide Super and new investors HESTA and Hostplus contributed to the fund.

The firm intends to invest A$50 million in 20-30 seed-stage biotech and medical device companies. It plans to invest the remainder in later rounds for those companies and other MRCF portfolio companies. ...